xtock-shutterstock-com-3
xtock / Shutterstock.com
7 January 2016AmericasDeclan Hamill and Megan Kendall

Pharma innovators in Canada: is utility standard uncertainty worth the risk?

The granting of Canadian patents is governed by the federal Patent Act and Patent Rules, and various regulations under them. They legislate that a patent may be obtained for an invention if it is new, non-obvious, and useful (the utility requirement). To meet the utility requirement, an invention must be capable of industrial application, meaning that the invention can be made and/or used in an industry of some kind. Utility is not a Canada-specific legal requirement. Rather, it is found in patent systems around the world and applies to all patented inventions, pharmaceutical or otherwise.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
26 January 2026   The court found the board applied the wrong legal standard when evaluating Guardant Health’s obviousness challenge to a University of Washington DNA sequencing patent.
Americas
23 January 2026   Just one pharma company is recognised in a report that lists the most world's most inventive countries and companies.
Americas
22 January 2026   A district court judge shuts down a Novartis rival from reopening validity and infringement arguments over an Entresto patent.